# AURA (Aura Biosciences, Inc.) - SEC EDGAR Financial Statements

> Aura Biosciences, Inc. reported $321.6M in total assets and a net loss of $136.9M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/AURA
- Markdown: https://convexityos.com/fundamentals/AURA.md
- SEC CIK: 0001501796
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001501796&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$145.2M | Operating profit |
| Net Income | FY 2025 | -$136.9M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.23 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$109.7M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $41.67M | Total debt: $16.17M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $90.30M | $73.30M | $65.23M | $42.24M | $25.16M | $18.04M |
| **Operating Income** | -$112.8M | -$96.12M | -$84.99M | -$60.30M | -$35.25M | -$22.21M |
| **EBITDA** | -$111.7M | -$94.89M | -$83.70M | -$59.12M | -$34.42M | -$21.38M |
| Income Before Tax | -$106.1M | -$86.81M | -$76.27M | -$58.76M | -- | -- |
| Income Tax Expense | $108K | $112K | $137K | $0 | $0 | $0 |
| **Net Income** | -$106.2M | -$86.92M | -$76.41M | -$58.76M | -$35.25M | -$22.21M |
| Basic EPS | -$1.76 | -$1.75 | -$1.93 | -$1.96 | -$8.95 | -$82.06 |
| **Diluted EPS** | -$1.76 | -$1.75 | -$1.93 | -$1.96 | -$8.95 | -$82.06 |
| Basic Shares Outstanding | 60.3M | 49.7M | 39.6M | 29.9M | 5.2M | 367.2K |
| Diluted Shares Outstanding | 60.3M | 49.7M | 39.6M | 29.9M | 5.2M | 367.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $24.74M | $30.75M | $27.96M | $21.90M | $22.18M | $22.88M | $23.34M | $22.33M |
| **Operating Income** | -$35.06M | -$48.07M | -$34.87M | -$27.24M | -$27.91M | -$28.61M | -$29.04M | -$27.81M |
| **EBITDA** | -$34.76M | -$47.77M | -$34.59M | -$26.96M | -$27.61M | -$28.31M | -$28.74M | -$27.52M |
| Income Before Tax | -$32.03M | -$45.61M | -$33.67M | -$25.54M | -$26.10M | -$26.97M | -$27.46M | -$25.81M |
| Income Tax Expense | $38K | $29K | $11K | $15K | $26K | $48K | $18K | $24K |
| **Net Income** | -$32.07M | -$45.64M | -$33.69M | -$25.56M | -$26.13M | -$27.02M | -$27.48M | -$25.83M |
| Basic EPS | -$0.29 | -$0.48 | -$0.50 | -- | -$0.40 | -$0.47 | -$0.55 | -- |
| **Diluted EPS** | -$0.29 | -$0.48 | -$0.50 | -- | -$0.40 | -$0.47 | -$0.55 | -- |
| Basic Shares Outstanding | 111.1M | 94.9M | 67.4M | -- | 65.9M | 58.0M | 50.1M | -- |
| Diluted Shares Outstanding | 111.1M | 94.9M | 67.4M | -- | 65.9M | 58.0M | 50.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $59.52M | $31.69M | $41.06M | $121.6M | $149.1M | $17.39M |
| **Cash & Short-Term Investments** | $144.2M | $31.69M | $41.06M | $188.8M | $149.1M | $17.39M |
| Other Current Assets | $660K | $1.83M | $2.41M | $715K | $66K | $16K |
| **Total Current Assets** | $149.7M | $160.6M | $231.8M | $196.7M | $153.7M | $18.45M |
| Property, Plant & Equipment, Net | $2.62M | $3.21M | $3.15M | $5.37M | $5.25M | $3.57M |
| Other Non-Current Assets | $471K | $518K | $509K | $423K | -- | -- |
| **Total Non-Current Assets** | $19.69M | $21.88M | $23.28M | $27.23M | $6.33M | $3.65M |
| **Total Assets** | $169.4M | $182.5M | $255.1M | $223.9M | $160.0M | $22.10M |
| Accounts Payable | $1.55M | $2.30M | $1.79M | $2.92M | $2.40M | $611K |
| **Total Current Liabilities** | $18.38M | $14.91M | $12.36M | $10.46M | $7.36M | $2.66M |
| **Total Non-Current Liabilities** | $14.13M | $15.62M | $16.87M | $17.89M | $360K | $80K |
| **Total Liabilities** | $32.52M | $30.53M | $29.23M | $28.35M | $7.71M | $2.74M |
| **Total Debt (incl. Leases)** | $17.38M | $18.77M | $19.56M | $20.86M | $975K | -- |
| Retained Earnings | -$480.4M | -$374.2M | -$287.3M | -$210.9M | -$152.1M | -$116.9M |
| Accumulated Other Comp. Income | -$102K | $263K | $539K | -$72K | -- | -- |
| **Total Stockholders' Equity** | $136.9M | $152.0M | $225.8M | $195.6M | $152.3M | -$108.7M |
| Total Equity | $136.9M | $152.0M | $225.8M | $195.6M | $152.3M | -$108.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.67M | $67.84M | $84.79M | $59.52M | $47.55M | $107.4M | $38.23M | $31.69M |
| **Cash & Short-Term Investments** | $41.67M | $67.84M | $84.79M | $144.2M | $47.55M | $107.4M | $38.23M | $31.69M |
| Other Current Assets | $851K | $819K | $1.06M | $660K | $2.58M | $2.62M | $1.77M | $1.83M |
| **Total Current Assets** | $303.1M | $329.0M | $118.5M | $149.7M | $170.1M | $184.0M | $134.5M | $160.6M |
| Property, Plant & Equipment, Net | $2.02M | $2.20M | $2.47M | $2.62M | $2.63M | $2.86M | $3.11M | $3.21M |
| Other Non-Current Assets | $1.17M | $1.14M | $517K | $471K | $277K | $185K | $0 | $518K |
| **Total Non-Current Assets** | $18.52M | $19.10M | $19.17M | $19.69M | $19.90M | $20.44M | $20.88M | $21.88M |
| **Total Assets** | $321.6M | $348.1M | $137.7M | $169.4M | $190.0M | $204.4M | $155.4M | $182.5M |
| Accounts Payable | $1.72M | $2.25M | $2.57M | $1.55M | $1.89M | $1.29M | $2.01M | $2.30M |
| **Total Current Liabilities** | $21.34M | $19.56M | $16.71M | $18.38M | $18.82M | $14.85M | $12.16M | $14.91M |
| **Total Non-Current Liabilities** | $12.85M | $13.30M | $13.72M | $14.13M | $14.53M | $14.92M | $15.27M | $15.62M |
| **Total Liabilities** | $34.19M | $32.86M | $30.43M | $32.52M | $33.36M | $29.77M | $27.43M | $30.53M |
| **Total Debt (incl. Leases)** | $16.17M | $16.59M | $16.99M | $17.38M | $17.75M | $18.11M | $18.44M | $18.77M |
| Common Stock | $1.0K | $1.0K | -- | -- | -- | -- | -- | -- |
| Retained Earnings | -$591.8M | -$559.7M | -$514.1M | -$480.4M | -$454.9M | -$428.7M | -$401.7M | -$374.2M |
| Accumulated Other Comp. Income | -$1.57M | -$670K | -$207K | -$102K | $69K | $25K | $105K | $263K |
| **Total Stockholders' Equity** | $287.4M | $315.3M | $107.2M | $136.9M | $156.7M | $174.6M | $128.0M | $152.0M |
| Total Equity | $287.4M | $315.3M | $107.2M | $136.9M | $156.7M | $174.6M | $128.0M | $152.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$106.2M | -$86.92M | -$76.41M | -$58.76M | -$35.25M | -$22.21M |
| Depreciation & Amortization | $1.13M | $1.22M | $1.29M | $1.18M | $831K | $831K |
| Stock-Based Compensation | $14.32M | $11.72M | $8.77M | $6.41M | $2.31M | $736K |
| Change in Payables | -$846K | $482K | -$1.04M | $340K | $1.05M | -$1.72M |
| **Operating Cash Flow** | -$84.74M | -$79.81M | -$63.85M | -$54.60M | -$32.41M | -$24.32M |
| Capital Expenditure | -$447K | -$1.25M | -$709K | -$1.09M | -$2.12M | -$771K |
| **Free Cash Flow** | -$85.19M | -$81.06M | -$64.56M | -$55.70M | -$34.53M | -$25.09M |
| Purchases of Investments | -$83.96M | -$59.10M | -$233.7M | -$119.8M | -- | -- |
| **Investing Cash Flow** | $35.59M | $68.82M | -$114.0M | -$67.87M | -$2.12M | -$771K |
| Common Stock Issued | $46.52M | $0 | -- | $86.65M | $78.70M | -- |
| **Financing Cash Flow** | $77.16M | $1.59M | $97.29M | $95.63M | $166.3M | $10.04M |
| **Net Change in Cash** | $28.01M | -$9.39M | -$80.52M | -$26.84M | $131.7M | -$15.06M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32.07M | -$45.64M | -$33.69M | -$25.56M | -$26.13M | -$27.02M | -$27.48M | -$25.83M |
| Depreciation & Amortization | $300K | $300K | $274K | $272K | $300K | $300K | $291K | $291K |
| Stock-Based Compensation | $4.92M | $12.37M | $3.82M | $3.28M | $3.69M | $3.83M | $3.51M | $2.94M |
| Change in Payables | -$525K | -$326K | $1.02M | -$430K | $602K | -$720K | -$298K | $310K |
| **Operating Cash Flow** | -$26.44M | -$32.50M | -$29.89M | -$20.47M | -$20.14M | -$20.77M | -$23.36M | -$23.95M |
| Capital Expenditure | -$80K | -$21K | -$102K | -$176K | -$45K | -$39K | -$187K | -$299K |
| **Free Cash Flow** | -$26.52M | -$32.52M | -$30.00M | -$20.64M | -$20.19M | -$20.81M | -$23.54M | -$24.25M |
| Purchases of Investments | -- | -- | -- | $0 | -$73.97M | -$9.98M | $0 | $0 |
| **Investing Cash Flow** | $114K | -$226.0M | $54.90M | $29.82M | -$44.02M | $19.98M | $29.81M | $29.70M |
| **Financing Cash Flow** | $206K | $241.8M | $300K | $2.77M | $4.36M | $69.93M | $96K | $543K |
| **Net Change in Cash** | -$26.12M | -$16.78M | $25.30M | $12.12M | -$59.80M | $69.13M | $6.55M | $6.29M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -77.6% | -57.2% | -33.8% | -30.0% | -23.1% | -- |
| Return on Assets (ROA) | -62.7% | -47.6% | -30.0% | -26.2% | -22.0% | -100.5% |
| Current Ratio | 8.15x | 10.77x | 18.76x | 18.81x | 20.90x | 6.94x |
| Quick Ratio | 7.84x | 2.13x | 3.32x | 18.05x | 20.27x | 6.54x |
| Debt to Equity | 0.13x | 0.12x | 0.09x | 0.11x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -47.6% | -41.6% | -104.8% | -77.6% | -68.0% | -58.1% | -74.0% | -57.2% |
| Return on Assets (ROA) | -42.6% | -37.6% | -81.6% | -62.7% | -56.0% | -49.6% | -60.9% | -47.6% |
| Current Ratio | 14.21x | 16.82x | 7.09x | 8.15x | 9.04x | 12.39x | 11.06x | 10.77x |
| Quick Ratio | 1.95x | 3.47x | 5.08x | 7.84x | 2.53x | 7.23x | 3.14x | 2.13x |
| Debt to Equity | 0.06x | 0.05x | 0.16x | 0.13x | 0.11x | 0.10x | 0.14x | 0.12x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
